Clinical Trials Browser

Completed × Has results × lutetium Lu 177 dotatate × Clear all

NCT01578239 2022-04-04

NETTER-1

Phase 3 Completed

231 enrolled 16 charts 4 FDA

Neuroendocrine Tumors

NCT03325816 2021-03-16

Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1/2 Completed

9 enrolled 10 charts

Small Cell Lung Carcinoma